{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:50:48Z","timestamp":1779328248363,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-155929"],"award-info":[{"award-number":["PJT-155929"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While the etiology remains elusive, macrophages and T cells in peripheral nerves are considered as effector cells mediating autoimmune peripheral neuropathy (APN), such as Guillain-Barre syndrome. By recognizing both pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) signals, TLRs play a central role in the initiation of both innate and adaptive immune responses. In this study, we aimed to understand the involvement of TLR4 in the pathogenesis of APN and explore the potential of TLR4 as a drug target for therapeutic use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>APN was induced by a partial ligation on one of the sciatic nerves in B7.2 (L31) transgenic mice which possess a predisposed inflammatory background. APN pathology and neurological function were evaluated on the other non-injured sciatic nerve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TLR4 and its endogenous ligand HMGB1 were highly expressed in L31 mice, in circulating immune cells and in peripheral nerves. Enhanced TLR4 signaling was blocked with TAK 242, a selective TLR4 inhibitor, before and after disease onset. Intraperitoneal administration of TAK 242 not only inhibited monocyte, macrophage and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell activation, but also reduced the release of pro-inflammatory cytokines. TAK 242 protected mice from severe myelin and axonal loss, resulting in a remarkable improvement in mouse motor and sensory functions. TAK 242 was effective in alleviating the disease in both preventive and reversal paradigms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study identified the critical contribution of TLR4-mediated macrophage activation in disease course and provided strong evidence to support TLR4 as a useful drug target for treating inflammatory autoimmune neuropathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-021-02126-x","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T03:03:03Z","timestamp":1616382183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Inhibition of TLR4 signaling protects mice from sensory and motor dysfunction in an animal model of autoimmune peripheral neuropathy"],"prefix":"10.1186","volume":"18","author":[{"given":"Oladayo","family":"Oladiran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang Qun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8816-9721","authenticated-orcid":false,"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"issue":"8","key":"2126_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B van den Berg","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469\u201382. https:\/\/doi.org\/10.1038\/nrneurol.2014.121.","journal-title":"Nat Rev Neurol"},{"issue":"18","key":"2126_CR2","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182904fcc","volume":"80","author":"B van den Berg","year":"2013","unstructured":"van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013;80(18):1650\u20134. https:\/\/doi.org\/10.1212\/WNL.0b013e3182904fcc.","journal-title":"Neurology."},{"issue":"2","key":"2126_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/187153011795564124","volume":"11","author":"EE Ubogu","year":"2011","unstructured":"Ubogu EE. Chemokine receptors as specific anti-inflammatory targets in peripheral nerves. Endocr Metab Immune Disord Drug Targets. 2011;11(2):141\u201353. https:\/\/doi.org\/10.2174\/187153011795564124.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2126_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cca.2015.02.039","volume":"449","author":"PR Bourque","year":"2015","unstructured":"Bourque PR, Chardon JW, Massie R. Autoimmune peripheral neuropathies. Clin Chim Acta. 2015;449:37\u201342. https:\/\/doi.org\/10.1016\/j.cca.2015.02.039.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"2126_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.bbadis.2014.06.013","volume":"1852","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC. Pathogenesis of immune-mediated neuropathies. Biochim Biophys Acta. 2015;1852(4):658\u201366. https:\/\/doi.org\/10.1016\/j.bbadis.2014.06.013.","journal-title":"Biochim Biophys Acta"},{"key":"2126_CR6","doi-asserted-by":"crossref","unstructured":"Fellner A, Barhum Y, Angel A, Perets N, Steiner I, Offen D, et al. Toll-like Receptor-4 inhibitor TAK-242 attenuates motor dysfunction and spinal cord pathology in an amyotrophic lateral sclerosis mouse model. Int J Mol Sci. 2017;18(8):1\u201316.","DOI":"10.3390\/ijms18081666"},{"key":"2126_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/ITT.S89795","volume":"5","author":"L Duffy","year":"2016","unstructured":"Duffy L, O'Reilly SC. Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments. Immunotargets Ther. 2016;5:69\u201380. https:\/\/doi.org\/10.2147\/ITT.S89795.","journal-title":"Immunotargets Ther"},{"issue":"6","key":"2126_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000127433","volume":"14","author":"YN Deng","year":"2007","unstructured":"Deng YN, Zhou WB. Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis. Neuroimmunomodulation. 2007;14(6):337\u201343. https:\/\/doi.org\/10.1159\/000127433.","journal-title":"Neuroimmunomodulation."},{"issue":"2","key":"2126_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neulet.2012.04.077","volume":"518","author":"M Gries","year":"2012","unstructured":"Gries M, Davies L, Liu Y, Bachhuber A, Spiegel J, Dillmann U, et al. Response of toll-like receptors in experimental Guillain-Barre syndrome: a kinetic analysis. Neurosci Lett. 2012;518(2):154\u201360. https:\/\/doi.org\/10.1016\/j.neulet.2012.04.077.","journal-title":"Neurosci Lett"},{"issue":"1","key":"2126_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuroscience.2008.12.034","volume":"159","author":"ZY Zhang","year":"2009","unstructured":"Zhang ZY, Zhang Z, Schluesener HJ. Toll-like receptor-2, CD14 and heat-shock protein 70 in inflammatory lesions of rat experimental autoimmune neuritis. Neuroscience. 2009;159(1):136\u201342. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.12.034.","journal-title":"Neuroscience."},{"issue":"2","key":"2126_CR11","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.3892\/mmr.2015.3730","volume":"12","author":"Y Du","year":"2015","unstructured":"Du Y, Zhang G, Zhang Z, Wang Q, Ma R, Zhang L, et al. Toll-like receptor 2 and -4 are involved in the pathogenesis of the Guillain-Barre syndrome. Mol Med Rep. 2015;12(2):3207\u201313. https:\/\/doi.org\/10.3892\/mmr.2015.3730.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2126_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000328200","volume":"19","author":"YZ Wang","year":"2012","unstructured":"Wang YZ, Liang QH, Ramkalawan H, Wang YL, Yang YF, Zhou WB, et al. Expression of toll-like receptors 2, 4 and 9 in patients with Guillain-Barre syndrome. Neuroimmunomodulation. 2012;19(1):60\u20138. https:\/\/doi.org\/10.1159\/000328200.","journal-title":"Neuroimmunomodulation."},{"key":"2126_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2051-5960-2-1","volume":"25","author":"M Yang","year":"2014","unstructured":"Yang M, Rainone A, Shi XQ, Fournier S, Zhang J. A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barre syndrome. Acta Neuropathol Commun. 2014;25:1\u201314.","journal-title":"Acta Neuropathol Commun"},{"key":"2126_CR14","first-page":"532","volume":"6","author":"M Yang","year":"2015","unstructured":"Yang M, Peyret C, Shi XQ, Siron N, Jang JH, Wu S, et al. Evidence from human and animal studies: pathological roles of CD8(+) T cells in autoimmune peripheral neuropathies. Front Immunol. 2015;6:532.","journal-title":"Front Immunol"},{"key":"2126_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbi.2018.04.001","volume":"71","author":"M Yang","year":"2018","unstructured":"Yang M, Shi XQ, Peyret C, Oladiran O, Wu S, Chambon J, et al. Effector\/memory CD8(+) T cells synergize with co-stimulation competent macrophages to trigger autoimmune peripheral neuropathy. Brain Behav Immun. 2018;71:142\u201357. https:\/\/doi.org\/10.1016\/j.bbi.2018.04.001.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2126_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1124\/mol.110.068064","volume":"79","author":"N Matsunaga","year":"2011","unstructured":"Matsunaga N, Tsuchimori N, Matsumoto T, Ii M. TAK-242 (resatorvid), a small-molecule inhibitor of toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol. 2011;79(1):34\u201341. https:\/\/doi.org\/10.1124\/mol.110.068064.","journal-title":"Mol Pharmacol"},{"key":"2126_CR17","first-page":"03","volume":"10","author":"SP Zehntner","year":"2003","unstructured":"Zehntner SP, Brisebois M, Tran E, Owens T, Fournier S. Constitutive expression of a costimulatory ligand on antigen-presenting cells in the nervous system drives demyelinating disease. FASEB J. 2003;10:03\u20130199.","journal-title":"FASEB J"},{"issue":"9","key":"2126_CR18","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.joca.2018.06.002","volume":"26","author":"E Krock","year":"2018","unstructured":"Krock E, Millecamps M, Currie JB, Stone LS, Haglund L. Low back pain and disc degeneration are decreased following chronic toll-like receptor 4 inhibition in a mouse model. Osteoarthr Cartil. 2018;26(9):1236\u201346. https:\/\/doi.org\/10.1016\/j.joca.2018.06.002.","journal-title":"Osteoarthr Cartil"},{"key":"2126_CR19","doi-asserted-by":"publisher","first-page":"577017","DOI":"10.1016\/j.jneuroim.2019.577017","volume":"335","author":"O Oladiran","year":"2019","unstructured":"Oladiran O, Yang M, Rivera VAG, Shi X, Huang J, Fournier S, et al. Murine cytomegalovirus infection in mice results in an acute inflammatory reaction in peripheral nerves. J Neuroimmunol. 2019;335:577017. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577017.","journal-title":"J Neuroimmunol"},{"key":"2126_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fnmol.2019.00314","volume":"12","author":"C Zheng","year":"2019","unstructured":"Zheng C, Chen J, Chu F, Zhu J, Jin T. Inflammatory role of TLR-MyD88 signaling in multiple sclerosis. Front Mol Neurosci. 2019;12:314.","journal-title":"Front Mol Neurosci"},{"key":"2126_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fphys.2017.00508","volume":"8","author":"W Gao","year":"2017","unstructured":"Gao W, Xiong Y, Li Q, Yang H. Inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to Nano therapeutics. Front Physiol. 2017;8:508. https:\/\/doi.org\/10.3389\/fphys.2017.00508.","journal-title":"Front Physiol"},{"key":"2126_CR22","doi-asserted-by":"publisher","first-page":"170352","DOI":"10.4061\/2011\/170352","volume":"2011","author":"Y Feng","year":"2011","unstructured":"Feng Y, Chao W. Toll-like receptors and myocardial inflammation. Int J Inflam. 2011;2011:170352.","journal-title":"Int J Inflam"},{"issue":"1","key":"2126_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","volume":"33","author":"SW Brubaker","year":"2015","unstructured":"Brubaker SW, Bonham KS, Zanoni I, Kagan JC. Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol. 2015;33(1):257\u201390. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112240.","journal-title":"Annu Rev Immunol"},{"issue":"1-2","key":"2126_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jneuroim.2013.01.006","volume":"257","author":"YZ Wang","year":"2013","unstructured":"Wang YZ, Tian FF, Liu H, Zhang W, Li J, Xiao B, et al. Macrophage migration inhibitory factor is necessary for the lipo-oligosaccharide-induced response by modulation of toll-like receptor 4 in monocytes from GBS patients. J Neuroimmunol. 2013;257(1-2):67\u201375. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.01.006.","journal-title":"J Neuroimmunol"},{"issue":"1-2","key":"2126_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jneuroim.2009.10.018","volume":"218","author":"KK Nyati","year":"2010","unstructured":"Nyati KK, Prasad KN, Verma A, Singh AK, Rizwan A, Sinha S, et al. Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barre syndrome in northern Indian population. J Neuroimmunol. 2010;218(1-2):116\u20139. https:\/\/doi.org\/10.1016\/j.jneuroim.2009.10.018.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"2126_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/acn3.744","volume":"6","author":"I Jahan","year":"2019","unstructured":"Jahan I, Ahammad RU, Khalid MM, Rahman MI, Hayat S, Islam B, et al. Toll-like receptor-4 299Gly allele is associated with Guillain-Barre syndrome in Bangladesh. Ann Clin Transl Neurol. 2019;6(4):708\u201315. https:\/\/doi.org\/10.1002\/acn3.744.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"2126_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.24442","volume":"78","author":"R Huizinga","year":"2015","unstructured":"Huizinga R, van den Berg B, van Rijs W, Tio-Gillen AP, Fokkink WJ, Bakker-Jonges LE, et al. Innate immunity to campylobacter jejuni in Guillain-Barre syndrome. Ann Neurol. 2015;78(3):343\u201354. https:\/\/doi.org\/10.1002\/ana.24442.","journal-title":"Ann Neurol"},{"issue":"1","key":"2126_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.4049\/jimmunol.0903014","volume":"185","author":"ML Kuijf","year":"2010","unstructured":"Kuijf ML, Samsom JN, van Rijs W, Bax M, Huizinga R, Heikema AP, et al. TLR4-mediated sensing of campylobacter jejuni by dendritic cells is determined by sialylation. J Immunol. 2010;185(1):748\u201355. https:\/\/doi.org\/10.4049\/jimmunol.0903014.","journal-title":"J Immunol"},{"issue":"1","key":"2126_CR29","doi-asserted-by":"publisher","first-page":"21890","DOI":"10.1038\/srep21890","volume":"6","author":"DQ Zhang","year":"2016","unstructured":"Zhang DQ, Wang R, Li T, Zhou JP, Chang GQ, Zhao N, et al. Reduced soluble RAGE is associated with disease severity of axonal Guillain-Barre syndrome. Sci Rep. 2016;6(1):21890. https:\/\/doi.org\/10.1038\/srep21890.","journal-title":"Sci Rep"},{"key":"2126_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jneuroim.2019.02.011","volume":"330","author":"DQ Zhang","year":"2019","unstructured":"Zhang DQ, Deng Y, Zhang LJ, Li LM, Qi Y, Wang J, et al. Elevated resistin levels may regulate high mobility group box 1 expression in Guillain-Barre syndrome. J Neuroimmunol. 2019;330:59\u201366. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.02.011.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"2126_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/00207454.2017.1418342","volume":"128","author":"Y Huang","year":"2018","unstructured":"Huang Y, Ying Z, Quan W, Xiang W, Xie D, Weng Y, et al. The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain-Barre syndrome. Int J Neurosci. 2018;128(8):729\u201335. https:\/\/doi.org\/10.1080\/00207454.2017.1418342.","journal-title":"Int J Neurosci"},{"issue":"4","key":"2126_CR32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/ijlh.12845","volume":"40","author":"X Li","year":"2018","unstructured":"Li X, Li W, Luo Y, Qin L, Su Q, Mo W. Can we assess severity of Guillain-Barre syndrome using absolute monocyte count? Int J Lab Hematol. 2018;40(4):488\u201392. https:\/\/doi.org\/10.1111\/ijlh.12845.","journal-title":"Int J Lab Hematol"},{"key":"2126_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cyto.2018.04.026","volume":"110","author":"M Debnath","year":"2018","unstructured":"Debnath M, Nagappa M, Talukdar PM, Subbanna M, Sundaravadivel P, Shivakumar V, et al. Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain Barre syndrome. Cytokine. 2018;110:58\u201362. https:\/\/doi.org\/10.1016\/j.cyto.2018.04.026.","journal-title":"Cytokine."},{"key":"2126_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3389\/fnins.2019.00717","volume":"13","author":"T Sun","year":"2019","unstructured":"Sun T, Chen X, Shi S, Liu Q, Cheng Y. Peripheral blood and cerebrospinal fluid cytokine levels in Guillain Barre syndrome: a systematic review and meta-analysis. Front Neurosci. 2019;13:717. https:\/\/doi.org\/10.3389\/fnins.2019.00717.","journal-title":"Front Neurosci"},{"issue":"1","key":"2126_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","volume":"84","author":"J Zhu","year":"1998","unstructured":"Zhu J, Mix E, Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barre syndrome. J Neuroimmunol. 1998;84(1):40\u201352. https:\/\/doi.org\/10.1016\/S0165-5728(97)00238-5.","journal-title":"J Neuroimmunol"},{"key":"2126_CR36","doi-asserted-by":"publisher","first-page":"4286364","DOI":"10.1155\/2018\/4286364","volume":"2018","author":"D Shen","year":"2018","unstructured":"Shen D, Chu F, Lang Y, Geng Y, Zheng X, Zhu J, et al. Beneficial or harmful role of macrophages in Guillain-Barre syndrome and experimental autoimmune neuritis. Mediators Inflamm. 2018;2018:4286364.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2126_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.immuni.2012.09.017","volume":"38","author":"MJ Richer","year":"2013","unstructured":"Richer MJ, Nolz JC, Harty JT. Pathogen-specific inflammatory milieux tune the antigen sensitivity of CD8(+) T cells by enhancing T cell receptor signaling. Immunity. 2013;38(1):140\u201352. https:\/\/doi.org\/10.1016\/j.immuni.2012.09.017.","journal-title":"Immunity."},{"issue":"5","key":"2126_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","volume":"24","author":"HL Zhang","year":"2013","unstructured":"Zhang HL, Zheng XY, Zhu J. Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev. 2013;24(5):443\u201353. https:\/\/doi.org\/10.1016\/j.cytogfr.2013.05.005.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2126_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0165-5728(92)90129-9","volume":"40","author":"JW Griffin","year":"1992","unstructured":"Griffin JW, George R, Lobato C, Tyor WR, Yan LC, D GJ. Macrophage responses and myelin clearance during wallerian degeneration: relevance to immune-meidated demyelination. J Neuroimmunol. 1992;40:153\u201366.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"2126_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","volume":"19","author":"B Schmidt","year":"1996","unstructured":"Schmidt B, Toyka KV, Kiefer R, Full J, Hartung H, Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve. 1996;19(4):474\u201387. https:\/\/doi.org\/10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9.","journal-title":"Muscle Nerve"},{"issue":"S1","key":"2126_CR41","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1002\/ana.410270716","volume":"27","author":"H Hartung","year":"1990","unstructured":"Hartung H, Toyka KV. T cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barre syndrome. Ann Neurol. 1990;27(S1):S57\u201363. https:\/\/doi.org\/10.1002\/ana.410270716.","journal-title":"Ann Neurol"},{"issue":"3","key":"2126_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/mus.23829","volume":"48","author":"S Chiang","year":"2013","unstructured":"Chiang S, Ubogu EE. The role of chemokines in Guillain-Barre syndrome. Muscle Nerve. 2013;48(3):320\u201330. https:\/\/doi.org\/10.1002\/mus.23829.","journal-title":"Muscle Nerve"},{"issue":"2","key":"2126_CR43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0165-5728(99)00100-9","volume":"98","author":"L Zou","year":"1999","unstructured":"Zou L, Pelidou S, Abbas N, Deretzi G, Mix E, Schaltzbeerg M, et al. Dynamics of production of MIP-1\u03b1, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J Neuroimmunol. 1999;98(2):168\u201375. https:\/\/doi.org\/10.1016\/S0165-5728(99)00100-9.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"2126_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/08830185.2017.1365146","volume":"36","author":"K Alvarez","year":"2017","unstructured":"Alvarez K, Vasquez G. Damage-associated molecular patterns and their role as initiators of inflammatory and auto-immune signals in systemic lupus erythematosus. Int Rev Immunol. 2017;36(5):259\u201370. https:\/\/doi.org\/10.1080\/08830185.2017.1365146.","journal-title":"Int Rev Immunol"},{"issue":"4","key":"2126_CR45","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e27","volume":"18","author":"JS Roh","year":"2018","unstructured":"Roh JS, Sohn DH. Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 2018;18(4):e27. https:\/\/doi.org\/10.4110\/in.2018.18.e27.","journal-title":"Immune Netw"},{"issue":"1","key":"2126_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","volume":"29","author":"U Andersson","year":"2011","unstructured":"Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29(1):139\u201362. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101323.","journal-title":"Annu Rev Immunol"},{"key":"2126_CR47","doi-asserted-by":"publisher","first-page":"758639","DOI":"10.1155\/2014\/758639","volume":"2014","author":"KK Nyati","year":"2014","unstructured":"Nyati KK, Prasad KN. Role of cytokines and toll-like receptors in the immunopathogenesis of Guillain-Barre syndrome. Mediators Inflamm. 2014;2014:758639.","journal-title":"Mediators Inflamm"},{"issue":"46","key":"2126_CR48","doi-asserted-by":"publisher","first-page":"12565","DOI":"10.1523\/JNEUROSCI.3027-07.2007","volume":"27","author":"A Boivin","year":"2007","unstructured":"Boivin A, Pineau I, Barrette B, Filali M, Vallieres N, Rivest S, et al. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci. 2007;27(46):12565\u201376. https:\/\/doi.org\/10.1523\/JNEUROSCI.3027-07.2007.","journal-title":"J Neurosci"},{"key":"2126_CR49","unstructured":"Wu S, Rau C, Lu T, Wu C, Wu Y, Tzeng S, et al. Knockout of TLR4 and TLR2 impair the nerve regenration by delayed demyelination but not remyelination. J Biomed Sci. 2013;20(62):1-7."}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-021-02126-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T03:03:46Z","timestamp":1616382226000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-021-02126-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2126"],"URL":"https:\/\/doi.org\/10.1186\/s12974-021-02126-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-138255\/v1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"assertion":[{"value":"28 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were in accordance with the guidelines of the Canadian Council on Animal Care and approved by the animal care committee of McGill University (protocol #5533).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}